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Background/aim: The most common causes of thyrotoxicosis include Graves’ disease (GD), toxic multinodular goiter (TMNG), toxic
adenoma (TA), and subacute granulomatous thyroiditis (SAT). In our study, we aimed to see whether neutrophil‐to‐lymphocyte ratio
(NLR), monocyte-to-lymphocyte ratio (MLR), platelet‐to‐lymphocyte ratio (PLR), and mean platelet volume (MPV) may be helpful in
the differential diagnosis of these diseases.
Materials and methods: We retrospectively analyzed the hospital records of the Endocrinology Clinic of our hospital between 2016 and
2019. We included data from 66 GD, 37 TA, and 35 SAT patients. We compared the data with those of 35 healthy subjects as controls.
Results: NLR, MLR, and PLR were found to be higher in the SAT group when compared to other groups. The post hoc analysis of
comparison of NLR, MLR, and PLR in each group showed that NLR and PLR were significantly different in the SAT group when
compared to the GD, TA, and controls groups (P < 0.001, P = 0.003, and P < 0.001 for NLR respectively and P < 0.001 for PLR in
all groups). MPV levels were different between groups (P = 0.007). However, the intergroup analysis (Tukey’s test) failed to show a
statistically significant difference for any of the groups. In patients with SAT, PLR and NLR were significantly higher than in the GD,
TA, and control groups. MLR was also higher in SAT when compared to other groups, but the difference was not statistically significant.
Conclusion: High PLR and NLR may be helpful to differentiate SAT from GD and TA, the other common causes of thyrotoxicosis.
Key words: Thyrotoxicosis, neutrophil, lymphocyte, monocyte, platelet, ratio

1. Introduction
Thyrotoxicosis describes disorders of excess thyroid
hormone with or without the increased thyroid hormone
synthesis. Hyperthyroidism is a pathological disorder
in which excess thyroid hormone is synthesized and
secreted by the thyroid gland. The most common causes
of hyperthyroidism include Graves’ disease (GD), toxic
multinodular goiter (TMNG), and toxic adenoma (TA) [1].
In other causes of thyrotoxicosis such as silent thyroiditis,
postpartum thyroiditis, and subacute granulomatous
thyroiditis (SAT), excess thyroid hormone is not related
to overfunction of the gland but comes from destructed
thyroid follicles [2,3].
Differential diagnosis of thyrotoxicosis is important
for treatment and a follow-up plan. SAT is a self-limited
inflammatory condition in which the treatment is based
on antiinflammatory drugs. However, GD and TA
necessitate treatment with antithyroid agents and possibly

thyroid surgery [1–3]. Differential diagnosis is based on
clinical features, physical examination, and biochemical
evaluation. To clarify the cause, a thyroid radioactive
iodine uptake (RAI) test is recommended [2–5]. RAI is
high in GD and TA but low in SAT. However, this is an
expensive procedure in which the patient is exposed to
radioactivity and must be partially isolated from his/her
household for days.
Neutrophil‐to‐lymphocyte ratio (NLR), monocyte-tolymphocyte ratio (MLR), and platelet‐to‐lymphocyte ratio
(PLR) have been investigated recently as new inflammatory
markers in many inflammatory, cardiovascular, and
malignant diseases [6,7]. Mean platelet volume (MPV)
is the volume of the average circulating platelets and is a
marker of platelet activation that is known to be associated
with inflammation [8].
In our study, we aimed to see whether NLR, MLR,
PLR, and MPV may be helpful in the differential diagnosis
of GD, TA, and SAT.
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2. Materials and methods
We retrospectively analyzed the hospital records of the
Endocrinology Clinic at the Ankara Training and Research
Hospital between 2016 and 2019. This study includes 66
GD, 37 TA, and 35 SAT patients. None of them had been
treated. The control group included 35 healthy subjects.
The study was approved by the ethics committee of the
Ankara Training and Research Hospital (approval date
and number: 12 December 2018–63/650).
GD is confirmed by the presence of conventional
symptoms of hyperthyroidism associated with a diffusely
enlarged goiter, elevated levels of free triiodothyronine
(FT3) and free thyroxine (FT4), decreased thyroidstimulating hormone (TSH) level, and positive thyroidstimulating hormone receptor antibody (TRAb),
according to laboratory results. TA is confirmed in the
presence of symptoms of hyperthyroidism with laboratory,
ultrasound, and radioactive iodine uptake test findings.
SAT diagnosis was based on typical clinical symptoms,
accelerated erythrocyte sedimentation rate (ESR), and
marked depression of thyroid uptake of radioactive iodine.
Pregnant patients or those who had hematologic
disease, cancer, severe renal or liver disease, ongoing
infection, chronic inflammatory disease, or autoimmune
disease were excluded from the study.
Demographic data of the patients and laboratory
parameters at the time of diagnosis were recorded.
NLR is calculated as the absolute count of neutrophils
divided by the absolute count of lymphocytes, PLR is
calculated as the absolute platelet count divided by the
absolute lymphocyte count, and MLR is calculated as
the absolute monocyte count divided by the absolute
lymphocyte count.
Blood samples were collected from both the patient and
the control group after 12 h of fasting. Hemogram samples
were collected in tubes with ethylenediamine tetraacetic
acid (EDTA) anticoagulant and processed within 1 h after
collection. All hematologic analyses were performed using
the Sysmex XN 3000 instrument analyzer (Kobe, Japan).
TSH, FT3, FT4, anti-TPO (thyroid peroxidase antibody),
anti-Tg (thyroglobulin), and TRAb were measured by
using the electrochemiluminescence method on the
Roche Cobas 8000 analyzer (Rotkreuz, Switzerland).
Blood samples for hormone analyses were collected in
standard gel separator tubes and performed after suitable
centrifugation. All samples were tested within 1 h.
2.1. Statistical analysis
SPSS 15 was used for statistical analysis (SPSS Inc.,
Chicago, IL, USA). Normality was tested using the
Shapiro–Wilk test. Data are presented as mean ± standard
deviation (SD) for normally distributed variables,
median (minimum–maximum) for nonnormally
distributed variables, and as the number of cases (%) for
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nominal variables. A chi-square test was performed for
categorical variables to assess differences between groups.
The comparisons between groups were performed by
ANOVA for parametric variables and Kruskal–Wallis
test for nonparametric variables. Post hoc comparisons
were evaluated with Tukey’s test for parametric variables
and Bonferroni correction Mann–Whitney U test for
nonparametric variables. Pearson correlation analysis was
used to test for correlation of normal variables considered
to be associated with inflammatory parameters, whereas
Spearman correlation analysis was used for variables
not showing a normal distribution. Covariance analysis
ANOVA was used to remove the effects of body mass index
(BMI) and age on the categorical independent variables
(MPV). Values of P < 0.05 were considered significant.
3. Results
Demographic and biochemical data of the participants are
shown in the Table. Mean ages were found to be different
(P < 0.001) between groups, whereas sex distribution
and BMI were similar. NLR, MLR, and PLR were
significantly different between groups. Other parameters
are summarized in the Table.
The inflammatory parameters tested, NLR, MLR, and
PLR, are shown in Figures 1a–1c. All parameters were
found to be higher in the SAT group when compared to
other groups.
In post hoc analysis, NLR was significantly different
in the SAT group when compared to the GD, TA, and
control groups (P < 0.001, P = 0.003, and P < 0.001
respectively). PLR was significantly different in the SAT
group (P < 0.001) when compared to all groups. MLR was
significantly different in SAT when compared to controls
(P < 0.001) and MLR was significantly different in the GD
group when compared to the TA and control groups (P =
0.009, P < 0.001 respectively).
MPV levels were different between groups (P = 0.007)
in post hoc analysis. However, the intergroup analysis
(Tukey’s test) failed to show a statistically significant
difference for any of the groups.
There was no correlation between age, BMI, thyroid
autoantibody levels, thyroid function, and the tested
inflammatory markers except a positive moderate
correlation between fT4 and MLR (r = 0.418). The
ANCOVA test showed that MPV values were independent
of age and BMI.
4. Discussion
NLR and PLR have been thought to be simple, inexpensive,
and easily reached predictors to evaluate systemic
inflammation. They have been used in several tumoral,
cardiac, inflammatory, and autoimmune diseases [9]. In
some studies, NLR and PLR were found to be higher in
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Table. Demographic and laboratory data of the participants.
GD patients
(n = 66)

TA patients
(n = 37)

SAT patients
(n = 35)

Control groups
(n = 35)

P**

Age, years

37.53 ± 11.68

52.16 ± 12.78

41.54 ± 8.98

45.37 ± 8.06

<0.001

Sex (F/M)

48/18

26/11

24/11

26/9

0.949

BMI (kg/m²)

26.78 ± 3.10

27.59 ± 3.19

28.11 ± 3.14

27.65 ± 2.80

0.287

WBC (10.9/L)

7.12 ± 1.71

8.45 ± 2.10

9.34 ± 2.23

7.20 ± 1.48

<0.001

Neutrophils (10.9/L)

3.68 (1.67–9.14)

4.53 (2.87–9.19

6 (3.85–14)

4.2 (1.33–7.5)

<0.001

Lymphocytes (10.9/L)

2.25 (1.1–4.39)

2.51 (1.54–4.09)

2.05 (0.84–3.94)

2.4 (1.43–3.3)

0.013

Platelets (10.9/L)

265 (176–427)

286 (187–462)

379 (241–560)

266 (178–397)

<0.001

MPV

10.39 ± 1.24

10.50 ± 1.28

9.75 ± 1.38

9.76 ± 1.06

0.007

TSH (mIU/L)

0.01 (0.003–0.08)

0.01 (0.01–0.29)

0.01 (0.01–0.17)

1.92 (0.42–4.8)

<0.001

FT4 (ng/dL)

3.67 (1.46–7.77)

1.57 (0.72–3.68)

2.96 (1.49–7.77)

1.13 (0.59–1.74)

<0.001

FT3 (ng/dL)

14.4 (1.89–32.11)

5.21 (2.82–11)

6.93 (3.3–19.55)

*

Anti-TPO (IU/mL)

165 (0.7–933)

13.1 (0.7–1087)

13.5 (0.5–60)

11 (0.2–400)

Anti-Tg (IU/mL)

110.5 (0.9–4000)

12.05 (0.9–240)

23 (0.9–768)

*

NLR

1.59 (0.47–5.23)

1.75(0.79–4.03)

2.84 (1.16–10.77)

1.68 (0.93–3.75)

PLR

116.47 (55.58–215.64) 111.05 (69.44–246.75) 178.09 (73.10–604.76) 110.83 (71.48–233.58)

<0.001

MLR

0.29 (0.13–0.83)

<0.001

0.22 (0.10–0.49)

0.36 (0.13–0.85)

0.20 (0.10–0.44)

<0.001
<0.001

Values are presented as median (range) or mean ± SD as appropriate. WBC = White blood cells, TSH = thyroid-stimulating hormone,
Anti-TPO = thyroid peroxidase antibody, Anti-Tg = antithyroglobulin, MPV = mean platelet volume, NLR = neutrophil-to-lymphocyte
ratio, PLR = platelet-to-lymphocyte ratio, MLR = monocyte-to-lymphocyte ratio, FT3 = free triiodothyronine, FT4 = free thyroxine,
BMI = body mass index.
*Could not be calculated due to missing data.
**P-value, calculated by chi-square (for categorical variables; age), ANOVA (for parametric variables), and Kruskal–Wallis (for
nonparametric variables). P < 0.05 is significant.

patients with rheumatoid arthritis, familial Mediterranean
fever, ulcerative colitis, psoriasis, and euthyroid chronic
autoimmune thyroiditis [10]. MLR was also used as a
marker in malignancies and cardiac and inflammatory
diseases [11]. MPV was also studied in many diseases and
was claimed to be associated with inflammation [12].
GD is the most frequent cause of hyperthyroidism.
GD is an autoimmune thyroid disease in which B and T
lymphocytes play a major role. B lymphocytes produce
antithyroid antibodies, whereas activated T lymphocytes
secrete proinflammatory cytokines [13,14]. Platelets and
lymphocytes are known to be reciprocally regulated in
disease processes. Lymphocyte activity is modulated by
platelets, soluble mediators, or direct cell-cell contact.
MPV, which refers to platelet size, is related to platelet
activation. Platelets actively react to the changes in
their microenvironment, leading to the release of
proinflammatory and prothrombotic substances. These
processes cause configurational and volume changes in the
platelets [15]. In our study we found that MPV was higher
in GD when compared to controls, but the difference was

not statistically significant. In the GD group MLR was
significantly higher than controls, but NLR and PLR were
similar. In a study by Dagdeviren et al., NLR was found
to be similar in GD when compared to other causes of
thyrotoxicosis and healthy controls [16].
TA is less common than GD, although its prevalence
increases with age and in the presence of dietary iodine
deficiency. Thyroid nodules become autonomous and
produce thyroid hormones independent of signals from
either TSH or thyrotropin-releasing hormone (TRH).
Unlike GD or SAT, autoimmunity or acute inflammation
does not play a role in the pathogenesis of TA [17]. In our
study, MLR, PLR, NLR, and MPV levels were found to be
similar to those of controls as expected.
SAT is an inflammatory disease characterized by painful
goiter, thyrotoxicosis, accelerated ESR, and depressed
thyroidal radioactive iodine uptake. SAT typically occurs
a few weeks after a viral infection. SAT is more common in
women than in men, with a ratio of 1.9–6:1, and generally
seen in the third to fifth decades [18]. Microscopically, early
infiltration into polymorphonuclear leukocytes is replaced
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Figure 1. a) Comparison of NLR between groups. b) Comparison of MLR between groups. c)
Comparison of PLR between groups. NLR = Neutrophil-to-lymphocyte ratio, MLR = monocyte-tolymphocyte ratio, PLR = platelet-to-lymphocyte ratio, GD = Graves’ disease, TA = toxic adenoma, SAT
= subacute thyroiditis.
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Figure 1. (Continued).

by lymphocytes and macrophages, and the normal follicles
may be replaced largely by an inflammatory reaction.
In time, monocytes and macrophages also play a role
in the pathogenesis [19]. As a result, it is clear that the
neutrophils, lymphocytes, monocytes, and macrophages
play an active role in the pathophysiology of SAT. In this
study we showed that MLR, PLR, and NLR were all higher
in patients with SAT when compared to the GD, TA, and
control groups. Among these, the difference in NLR and
PLR was statistically significant. This may be related to the
activation of monocytes and platelets early in the disease
process as well as an increase in the number of platelets
[20].
There are limitations to our study. First, we conducted
a retrospective study. Second, mean ages were different
between groups. This is probably related to the differing

age distribution of these different diseases. GD is more
common in the third to fourth decades whereas toxic
adenoma is seen in older patients. Unfortunately, the
control group is not age-matched when all three different
etiologies of thyrotoxicosis are considered. However, the
tested parameters are found to be independent of age in
correlation analysis, so we think that higher NLR and PLR
in SAT cannot be attributed to age.
In our study, we evaluated and compared NLR, MLR,
PLR, and MPV in newly diagnosed thyrotoxic patients. We
think that NLR and PLR may be helpful to differentiate SAT
from other causes of thyrotoxicosis before going further
with more expensive and difficult diagnostic studies such
as radioactive iodine uptake. Larger studies are needed to
see if these new inflammatory markers may be helpful in
the diagnosis of GD and other causes of thyrotoxicosis.
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